Back to Results
First PageMeta Content
Pharmaceutical sciences / Compounding / Form FDA 483 / Office of Criminal Investigations / Office of Regulatory Affairs / Pharmacy / Federal Food /  Drug /  and Cosmetic Act / Center for Drug Evaluation and Research / Food and Drug Administration / Health / Medicine


FDA’S OVERSIGHT OF NECC AND AMERIDOSE: A HISTORY OF MISSED OPPORTUNITIES? PRELIMINARY MAJORITY STAFF REPORT COMMITTEE ON ENERGY AND COMMERCE U.S. HOUSE OF REPRESENTATIVES
Add to Reading List

Document Date: 2013-04-16 08:07:33


Open Document

File Size: 577,01 KB

Share Result on Facebook

City

Framingham / Boston / Westborough / /

Company

NECC’S SISTER COMPANY / FDA NWE-DO / Pharmacy / Registration / Ameridose / NECC / NEW ENGLAND COMPOUNDING PHARMACY INC. / Fill Gaps / /

Country

United States / /

Event

Product Issues / FDA Phase / Product Recall / /

Facility

In Medical Center Pharmacy / Western States Medical Center / Wedgewood Pharmacy / Pharmacy Compounding / FDA headquarters / Causeway Street / /

IndustryTerm

drug product / drug manufacturer / drug manufacturing practice / compounded products / manufacturing / healthcare providers / drug products / healthcare facilities / injectable steroid solution / steroid solution / search warrant / betamethasone product / drug manufacturing / /

MedicalCondition

sterility / persistent fungal infections / chronic pain / fungal meningitis / pain / meningitis / /

Organization

Massachusetts Board of Pharmacy/Division of Professional Licensure / U.S. Securities and Exchange Commission / Majority Committee / FDA’s office of Criminal Investigations / Circuit Court / U.S. Supreme Court / office of Criminal Investigations / Criminal Division of the U.S. / New England Compounding Center / Oversight Subcommittee / FDA / Labeling Compliance / Massachusetts Department of Public Health / Massachusetts Board of Registration / Reform Board of Pharmacy and Fill Gaps / Food and Drug Administration / office of Compliance / office of Regulatory Affairs / FDA New England District Office / Centers for Disease Control and Prevention / Subcommittee on Oversight and Investigations / CONGRESS / U.S. Court of Appeals / office of Enforcement / U.S. Attorney’s Office / U.S. HOUSE OF REPRESENTATIVES / Massachusetts office Abbreviations Massachusetts Department of Public Health / Center for Drug Evaluation and Research / Center for Drug Evaluation / Western States Medical Center / New England District Office / /

Person

Joshua Sharfstein Steven Silverman Michael / Gregory Conigliaro / Kennedy / Kristina Joyce / Patrick Announces / Alyson Saben Douglas Stearn Mutahar / Margaret Hamburg Joshua Sharfstein Steven / Rick Friedman Michael Rogers Michael / Samia Nasr Tamara Ely Pamela Lee Deborah / David Horowitz / Lisa Conigliaro-Cadden / David Elder / Steven Silverman Michael Levy Kathleen / Carla Conigliaro / Margaret Hamburg / Michael Levy Kathleen Anderson Samia / Compliance Branch / Mark Lookabaugh / Michael Chappell Alyson Saben Douglas / Barry Cadden / Michael Rogers Michael Chappell Alyson / Douglas Stearn Mutahar Shamsi Amber / Pamela Lee Deborah Autor Rick Friedman Michael / Deval Patrick / Joyce Lovelace / Steven Galson / /

Position

Director / Division / Director / Division of Compliance Policy / physician / licensed pharmacist / head / CEO / Chief Counsel / President and co-owner / pharmacist / Acting Associate Commissioner / ORA Deputy Director / CDER Team Leader / Compounding Team / Deputy Commissioner / Director / Division of Manufacturing and Product Quality / Officer / Consumer Safety Officer / Governor / Assistant Director / Director / Division of Field Investigations / Deputy Director / Director / Commissioner / Acting Commissioner / NWE-DO Director / Consumer Safety Officer / New England Dist / /

Product

methylprednisolone acetate / hydroxyprogesterone caproate / firms / MedWatch system / drugs / MedWatch / steroid / lots / products / batches / /

ProvinceOrState

Texas / Massachusetts / FDA New England District / /

URL

http /

SocialTag